In patients without radiation therapy, both BICD1 and MGMT expression did not show significant impact on the overall survival of GBM patients, but BICD1 expression showed higher impact (P=0.403971) than MGMT expression (P=0.514530) (Figure 6D). The gene discussed is BICD1; the disease is glioblastoma.